Growth Metrics

Axogen (AXGN) Free Cash Flow Growth (1y) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -1.82%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 226.77%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 9.73%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -51.69%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -109.40%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 133.09%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 363.84%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 108.16%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 29.12%
10 Axogen 2.00 Bn 1.90 Bn 46.19 Mn 90.89%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 90.89%
Dec 31, 2025 -105.84%
Sep 30, 2025 89.26%
Jun 30, 2025 74.42%
Mar 31, 2025 -5.11%
Dec 31, 2024 160.96%
Sep 30, 2024 -36.40%
Jun 30, 2024 62.10%
Mar 31, 2024 -9.00%
Dec 31, 2023 -151.52%
Sep 30, 2023 151.22%
Jun 30, 2023 128.53%
Mar 31, 2023 27.11%
Dec 31, 2022 -256.85%
Sep 30, 2022 -155.67%
Jun 30, 2022 -14.23%
Mar 31, 2022 -15.62%
Dec 31, 2021 91.72%
Sep 30, 2021 -37.45%
Jun 30, 2021 48.46%
Mar 31, 2021 -18.67%
Dec 31, 2020 -312.16%
Sep 30, 2020 392.18%
Jun 30, 2020 -180.31%
Mar 31, 2020 -25.48%
Dec 31, 2019 17.06%
Sep 30, 2019 40.54%
Jun 30, 2019 -35.01%
Mar 31, 2019 -50.63%
Dec 31, 2018 -238.61%
Sep 30, 2018 -246.89%
Jun 30, 2018 -86.60%
Mar 31, 2018 -53.09%
Dec 31, 2017 -75.83%
Sep 30, 2017 4.78%
Jun 30, 2017 17.84%
Mar 31, 2017 19.15%
Dec 31, 2016 78.55%
Sep 30, 2016 15.59%
Jun 30, 2016 21.33%
Mar 31, 2016 -98.89%
Dec 31, 2015 -54.98%
Sep 30, 2015 -27.18%
Jun 30, 2015 -36.35%
Mar 31, 2015 24.69%
Dec 31, 2014 -5.41%
Sep 30, 2014 19.18%
Jun 30, 2014 -4.96%
Mar 31, 2014 -24.98%
Dec 31, 2013 26.27%
Sep 30, 2013 -59.48%
Jun 30, 2013 -156.33%
Mar 31, 2013 -6.76%
Dec 31, 2012 -53.77%
Sep 30, 2012 24.63%
Jun 30, 2012 24.35%
Mar 31, 2012 -116.74%
Dec 31, 2011 -211.40%
Sep 30, 2011 -76.87%